(53 days)
The SonoScape S40 device is a general-purpose ultrasonic imaging instrument intended for use by a qualified physician for evaluation of Fetal, Abdominal, Pediatric, Small Organ (breast, testes, thyroid), Cephalic(neonatal and adult), Trans-rectal, Trans-vaginal, Peripheral Vascular, Musculo-skeletal (Conventional and Superficial), Cardiac (neonatal and adult), OB/Gyn and Urology.
The SonoScape S40 Digital Color Doppler Ultrasound System is an integrated preprogrammed color ultrasound imaging system, capable of producing high detail resolution intended for clinical diagnostic imaging applications. The all digital architecture with progressive dynamic receive focusing allows the system to maximize the utility of all imaging transducers to enhance the diagnostic utility and confidence provided by the system. The exam dependent default setting allows the user to have minimum adjustment for imaging the patient, while the in-depth soft-menu control allows the advanced user to set the system for different situations. The architecture allows cost-effective system integration to a variety of upgrade-able options and features. This SonoScape system is a general purpose, software controlled, diagnostic ultrasound system. Its basic function is to acquire ultrasound data and display the image in B-Mode (including Tissue Harmonic Image), M-Mode, TDI, Color-Flow Doppler, Pulsed Doppler and Power Doppler, or a combination of these modes, 3D/4D.
This document describes the SonoScape S40 Digital Color Doppler Ultrasound System and its substantial equivalence to a predicate device (SonoScape S6). The information provided is primarily for regulatory submission and does not detail a clinical study with an acceptance criterion for device performance in the way a clinical trial for an AI algorithm would. Instead, it focuses on technical specifications and compliance with safety standards to demonstrate substantial equivalence.
Based on the provided text, a "study" in the sense of a clinical performance study with human readers or standalone algorithm performance, as typically found in AI/ML device submissions, was not conducted. The study supporting this device's acceptance is a bench testing and comparison study against a predicate device and relevant safety standards.
Here's a breakdown of the requested information based on the provided 510(k) summary:
1. Table of Acceptance Criteria and Reported Device Performance
The acceptance criteria are primarily defined by the performance characteristics of the predicate device (SonoScape S6) and compliance with international safety and performance standards. The "reported device performance" is the comparison of the SonoScape S40 against the S6.
| Feature / Parameter | Acceptance Criteria (Predicate Device S6 Performance) | Reported Device Performance (SonoScape S40) | Remark |
|---|---|---|---|
| Intended Use | General-purpose ultrasonic imaging for Fetal, Abdominal, Pediatric, Small Organ, Cephalic, Trans-rectal, Trans-vaginal, Peripheral Vascular, Musculo-skeletal, Cardiac, OB/Gyn, Urology. | Same | Same (Substantially Equivalent) |
| Classification | Same as predicate: Ultrasonic Pulsed Doppler Imaging System, Ultrasonic Pulsed Echo Imaging System, Diagnostic Ultrasound Transducer; Class II; Product Code IYN, IYO, ITX. | Same | Same (Substantially Equivalent) |
| Supported Probes | Specific list of Linear, Curved, Micro-curved, and Phased Array probes. | Includes new L752, C353, C322, 5P2, 8P1 probes, and different configuration of Phased Array probes (2P2, 3P1). Handles from 2 to 15 MHz. | Differences noted, but all comply with IEC 60601-2-37. Considered Substantially Equivalent in safety and effectiveness; no new risk. New probes potentially offer improved image quality. |
| Channel Beam Former | 64 channel full digital beam former. | 128 channel full digital beam former. | S40 has better image quality due to 128 channels. Considered Substantially Equivalent in safety and effectiveness. |
| Image Sector Size | 32 lines to full B (256 lines). | 32 lines to full B (512 lines). | S40 has better image quality due to 512 lines. Considered Substantially Equivalent in safety and effectiveness. |
| Display Depth | Max 32.9 cm; (Probe depend); Error range: ±3%. | Same (Max 32.9 cm; (Probe depend); Error range: ±3%). | Same (Substantially Equivalent) |
| Distance Measurement | 0~31.0 cm; Error range: ±3%. | Same (0~31.0 cm; Error range: ±3%). | Same (Substantially Equivalent) |
| Area Measurement | Max. ≥855 cm²; Error range: ±7%. | Same (Max. ≥855 cm²; Error range: ±7%). | Same (Substantially Equivalent) |
| Angle Measurement | 10~193°; Error range: ±3%. | Same (10~193°; Error range: ±3%). | Same (Substantially Equivalent) |
| Circumference Measurement | 200 cm; Error range: ±3%. | Same (200 cm; Error range: ±3%). | Same (Substantially Equivalent) |
| Volume Measurement | Max. 25000 cm³; Error range: ±10%. | Same (Max. 25000 cm³; Error range: ±10%). | Same (Substantially Equivalent) |
| M-Mode Time | 2,4,6,8 S; Error range: ±1%. | Same (2,4,6,8 S; Error range: ±1%). | Same (Substantially Equivalent) |
| Heart Rate | 8 ~ 1000 beats/sec; Error range: ±3%. | Same (8 ~ 1000 beats/sec; Error range: ±3%). | Same (Substantially Equivalent) |
| Slope | 1300 cm/s; Error range: ±3%. | Same (1300 cm/s; Error range: ±3%). | Same (Substantially Equivalent) |
| Velocity (PW) | 0.04-2940 cm/s; Angle ≤60°, ≤5% error. | Same (0.04-2940 cm/s; Angle ≤60°, ≤5% error). | Same (Substantially Equivalent) |
| Velocity (CW) | 0.13-3529 cm/s; Angle ≤60°, ≤5% error. | 0.12-3795 cm/s; Angle ≤60°, ≤5% error. | S40 has better/wider velocity range. Considered Substantially Equivalent in safety and effectiveness. |
| Velocity (Color) | 2-226 cm/s; Angle ≤60°, ≤5% error. | 1-298 cm/s; Angle ≤60°, ≤5% error. | S40 has better/wider velocity range. Considered Substantially Equivalent in safety and effectiveness. |
| Acoustic Output | Track 3:MI, TIS, TIC, TIB (Derated Ispta: 720Mw/cm2 maximum, TIS/TIB/TIC: 6.0 Maximum, Mechanical Index: 1.9 Maximum, or Derated Isppa: 190W/cm2 max). | Same (Track 3:MI, TIS, TIC, TIB Derated ispta: 720Mw/cm2 maximum, TIS/TIB/TIC: 6.0 Maximum, Mechanical Index: 1.9 Maximum, or Derated Isppa: 190W/cm2 max). | Same (Substantially Equivalent) - Measured and calculated per NEMA UD 2: 2004. |
| Electrical Safety | Complies with IEC 60601-1. | Complies with IEC 60601-1. | Same (Substantially Equivalent) |
| EMC | Complies with IEC 60601-1-2. | Complies with IEC 60601-1-2. | Same (Substantially Equivalent) |
| Performance (Safety) | Complies with IEC 60601-2-37. | Complies with IEC 60601-2-37. | Same (Substantially Equivalent) |
| Biocompatibility | Complies with ISO 10993-5, ISO 10993-10. | Complies with ISO 10993-5, ISO 10993-10. | Same (Substantially Equivalent) |
| Level of Concern of Software | Moderate. | Moderate. | Same (Substantially Equivalent) |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size: Not explicitly stated as a "test set" in the context of a clinical performance study on patients. The testing involved laboratory testing to verify design specifications and compliance with standards. It's implied that various transducers were tested for their acoustic output and safety characteristics.
- Data Provenance: The testing was conducted internally by SonoScape Company Limited ("Laboratory testing was conducted to verify that the S40 system with added transducer met all design specification..."). The country of origin for the data would be China, where SonoScape is based.
- Retrospective or Prospective: This was likely prospective bench testing and engineering validation against predefined specifications and standards, rather than retrospective or prospective clinical data collection from patients.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
- This type of information is not provided in the 510(k) summary. The submission does not describe a clinical study requiring human expert ground truth for interpretation of images. The ground truth for the technical measurements and safety compliance would be established by validated test equipment and calibration standards, assessed by qualified engineers and technicians, not clinical experts for diagnostic accuracy.
4. Adjudication Method for the Test Set
- Not applicable. Given that no clinical test with human experts interpreting results was conducted, an adjudication method like 2+1 or 3+1 is not relevant to this submission.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was Done
- No, an MRMC comparative effectiveness study was not done. The summary explicitly states: "No clinical testing was required." (Section 8). The comparison was primarily technical specifications against a predicate device.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was Done
- Not applicable / No. This device is a diagnostic ultrasound system, not an AI algorithm intended for standalone diagnostic interpretation. Its performance is evaluated based on its ability to acquire and display ultrasound data accurately and safely, matching or improving upon the predicate device's technical specifications.
7. The Type of Ground Truth Used (expert consensus, pathology, outcomes data, etc.)
- The "ground truth" for the acceptance of this device relies on:
- Predicate Device Performance: The established performance characteristics and safety profile of the legally marketed SonoScape S6 ultrasound system.
- International Safety and Performance Standards: Compliance with standards like IEC 60601-1, IEC 60601-1-2, IEC 60601-2-37, NEMA UD 2, NEMA UD3, ISO 10993-5, and ISO 10993-10.
- Bench Test Results: Direct measurements of technical parameters (e.g., measurement accuracy for distance, area, velocity, acoustic output) using calibrated equipment.
8. The Sample Size for the Training Set
- Not applicable. This device is a hardware and software system, not an AI/ML algorithm that is "trained" on a specific dataset. Its development involves standard engineering design, testing, and validation processes.
9. How the Ground Truth for the Training Set Was Established
- Not applicable. As there is no "training set" in the AI/ML sense, there is no ground truth established for one. The device's functionality is based on established ultrasound physics and engineering principles.
{0}------------------------------------------------
510(k) Submission
510(k) Summary
JUN 2 1 2013
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR §807.92.
The assigned 510(k) number: K131213
-
- Date of submission: April 26, 2013
-
- Submitter
SonoScape Company Limited Address: Yizhe Building, Yuquan Road,Nanshan, Shenzhen 518051, P.R.China Tel: (86) 755-26722890 Fax: (86) 755-26722850 Contact Person: Toki Wu E-mail:Faith@sonoscape.net/wusq@sonoscape.net
3. Proposed Device Identification
Trade/Proprietary Name: S40 Digital Color Doppler Ultrasound System Common Name: Diagnostic Ultrasound System and Transducers Classification:
21 FR 892.1550 Ultrasonic Pulsed Doppler Imaging System (90-IYN)
21 FR 892.1560 Ultrasonic Pulsed Echo Imaging System (90-IYO)
21 CFR 892.1570 Diagnostic Ultrasound Transducer (90-ITX)
Classification Panel: Radiology
Device Class: Il
4. Legally Marketed Predicate Device
SonoScape Company Limited, Diagnostic Ultrasound System, Model S6 has been cleared by FDA through 510(k) No.K112602 (Decision Date - November 07, 2011).
{1}------------------------------------------------
5. Device Description
The SonoScape S40 Digital Color Doppler Ultrasound System is an integrated preprogrammed color ultrasound imaging system, capable of producing high detail resolution intended for clinical diagnostic imaging applications.
The all digital architecture with progressive dynamic receive focusing allows the system to maximize the utility of all imaging transducers to enhance the diagnostic utility and confidence provided by the system. The exam dependent default setting allows the user to have minimum adjustment for imaging the patient, while the in-depth soft-menu control allows the advanced user to set the system for different situations. The architecture allows cost-effective system integration to a variety of upgrade-able options and features.
This SonoScape system is a general purpose, software controlled, diagnostic ultrasound system. Its basic function is to acquire ultrasound data and display the image in B-Mode (including Tissue Harmonic Image), M-Mode, TDI, Color-Flow Doppler, Pulsed Doppler and Power Doppler, or a combination of these modes, 3D/4D.
6. Intended Use Statement
The SonoScape S40 device is a general-purpose ultrasonic imaging instrument intended for use by a qualified physician for evaluation of Fetal, Abdominal, Pediatric, Small Organ (breast, testes, thyroid), Cephalic(neonatal and adult), Trans-rectal, Trans-vaginal, Peripheral Vascular, Musculo-skeletal (Conventional and Superficial), Cardiac (neonatal and adult), OB/Gyn and Urology.
Transducer Information is shown in the table 1.
| No. | Probe | Type | FrequencyRange | Intended Use |
|---|---|---|---|---|
| 1 | C344 | curved Array | 2.0-5.0 MHz | Fetal / Abdominal/ Ob/GYN |
| 2 | C353 | curved Array | 2.0-6.0 MHz | Fetal / Abdominal/ Ob/GYN |
| 3 | C322 | curved Array | 2.0-6.0 MHz | Fetal / Abdominal/ Ob/GYN |
| 4 | VC6-2 | curved Array | 2.0-6.0 MHz | Fetal / Abdominal/ Ob/GYN |
| 5 | 6V1 | Micro-curvedArray | 4.0-8.0 MHz | Trans-rectalTrans-vaginal |
| 6 | 6V3 | Micro-curved | 5.0-9.0 MHz | Trans-rectal |
Table 1 Transducer Information
510(k) Summary
{2}------------------------------------------------
510(k) Submission
| No. | Probe | Type | FrequencyRange | Intended Use |
|---|---|---|---|---|
| Array | Trans-vaginal | |||
| 7 | L741 | Linear Array | 5.0-10.0 MHz | Small Organ (breast, thyroid, testes)Musculo-skeletal (Conventional)Peripheral vessel |
| 8 | L742 | Linear Array | 5.0-12.0 MHz | Small Organ (breast, thyroid, testes)Musculo-skeletal (Conventional)Musculo-skeletal (Superficial)Peripheral vessel |
| 9 | L752 | Linear Array | 5.0-12.0 MHz | Small Organ (breast, thyroid, testes)Musculo-skeletal (Conventional)Musculo-skeletal (Superficial)Peripheral vessel |
| 10 | 2P2 | Phase Array | 1.0-5.0 MHz | AbdominalCephalic(neonatal and adult)Cardiac (neonatal and adult) |
| 11 | 3P1 | Phase Array | 1.0-5.0 MHz | AbdominalCephalic(neonatal and adult)Cardiac (neonatal and adult) |
| 12 | 5P2 | Phase Array | 3.0-8.0 MHz | PediatricNeonatal CephalicCardiac Pediatric |
| 13 | 8P1 | Phase Array | 4.0-12.0 MHz | PediatricNeonatal CephalicCardiac Pediatric |
7. Testing
Laboratory testing was conducted to verify that the S40 system with added transducer met all design specification and was substantially equivalent to the Predicate Device. The device has been found to conform to applicable medical device safety standards in regards to thermal, mechanical and electrical safety as well as biocompatibility. The acoustic output is measured and calculated per "NEMA UID 2: 2004 Acoustic Output Measurement Standard for Diagnostic Ultrasound Equipment".
510(k) Summary
{3}------------------------------------------------
| StandardsNo. | Standards Title | Version | Date |
|---|---|---|---|
| IEC 60601-1 | Medical Electrical Equipment - Part1.General Requirements for Safety | 1988+A1:1991+A2:1995 | 10/31/2005 |
| IEC60601-1-2 | Medical Electrical Equipment, Part 1-2:General Requirements for Safety -Collateral Standard: ElectromagneticCompatibility - Requirements and Tests | 2007 | 03/01/2007 |
| IEC60601-2-37 | Medical Electrical Equipment, Part 2-37:Particular Requirements for the Safety ofUltrasonic Medical Diagnostic andMonitoring Equipment | 2007 | 08/01/2007 |
| NEMA UD 2 | Acoustic Output Measurement Standard forDiagnostic Ultrasound Equipment Version 3 | 2004 | 01/01/2004(R 2009) |
| NEMA UD3 | Standard for Real-Time Display of Thermaland Mechanical Acoustic Output Indices onDiagnostic Ultrasound Equipment | 2004 | 01/01/2004(R 2009) |
| ISO 10993-5 | Biological evaluation of medical devices -Part 5: Tests for In Vitro cytotoxicity | 1999 | 05/15/1999 |
| ISO10993-10 | Biological evaluation of medical devices -Part 10: Tests for irritation and delayed-typehypersensitivity | 2002 | 09/01/2002 |
Tab 2 Applicable Safety Standards
8. Clinical Test:
No clinical testing was required.
9. Comparison Table
The differences between the S40 and the predicate device S6 in almost every part are listed in the tables below.
{4}------------------------------------------------
| ID | Items | Proposed DeviceSonoScape S40 | Predicate DeviceSonoScape S6 | Remark |
|---|---|---|---|---|
| 1 | Intended Use | The device is ageneral-purpose ultrasonicimaging instrumentintended for use by aqualified physician forevaluation of Fetal,Abdominal, Pediatric, SmallOrgan (breast, testes,thyroid), Cephalic (neonataland adult), Trans-rectal,Trans-vaginal, PeripheralVascular, Musculo-skeletal(Conventional andSuperficial), Cardiac(neonatal and adult),Urology and OB/Gyn. | The device is ageneral-purpose ultrasonicimaging instrumentintended for use by aqualified physician forevaluation of Fetal,Abdominal, Pediatric, SmallOrgan (breast, testes,thyroid), Cephalic(neonataland adult), Trans-rectal,Trans-vaginal, PeripheralVascular, Musculo-skeletal(Conventional andSuperficial), Cardiac(neonatal and adult),OB/Gyn and Urology. | Same |
Table 3 Intended Use Comparison
·
Table 4 General Comparison
| ID | Comparison Items | Proposed DeviceSonoScape S40 | Predicate DeviceSonoScape S6 | Remark |
|---|---|---|---|---|
| 2 | Classification Name | Ultrasonic Pulsed DopplerImaging SystemUltrasonic Pulsed EchoImaging SystemDiagnostic UltrasoundTransducer | Ultrasonic Pulsed DopplerImaging SystemUltrasonic Pulsed EchoImaging SystemDiagnostic UltrasoundTransducer | Same |
| 3 | Product Code | 90-IYN/90-IYO/90-ITX | 90-IYN/90-IYO/90-ITX | Same |
| 4 | Regulation Number | 892.1550/892.1560/892.1570 | 892.1550/892.1560/892.1570 | Same |
| 5 | Panel | Radiology | Radiology | Same |
| 6 | Class | II | II | Same |
| 7 | Probe Type &Connectors | L741 Linear Array, 5.0-10.0 MHzL742 Linear Array, 5.0-12.0 MHzL752 Linear Array, 5.0-12.0 MHz | L741 Linear Array, 5.0-10.0 MHzL742 Linear Array, 5.0-12.0 MHzL743 Linear Array, 5.0-10.0 MHz | SEAnalysis1 |
510(k) Summary
8-5
{5}------------------------------------------------
510(k) Submission
| ID | ComparisonItems | Proposed DeviceSonoScape S40 | Predicate DeviceSonoScape S6 | Remark |
|---|---|---|---|---|
| C344 Curved Array, 2.0-5.0MHzC322 Curved Array, 2.0-6.0MHzC353 Curved Array, 2.0-6.0MHz | C344 Curved Array, 2.0-5.0MHzC362 Curved Array, 2.0-6.0MHz | |||
| C611 Micro-curved Array,4.0-8.0 MHz | ||||
| VC6-2 Curved Array, 2.0-6.0MHz6V1 Micro-curved Array,4.0-8.0 MHz6V3 Micro-curved Array,5.0-9.0 MHz | VC6-2 Curved Array, 2.0-6.0MHz6V1 Micro-curved Array,4.0-8.0 MHz6V3 Micro-curved Array,5.0-9.0 MHzEC9-5 Micro-curved Array,5.0-9.0 MHz | |||
| 2P2 Phased Array, 1.0-5.0MHz3P1 Phased Array, 1.0-5.0MHz5P2 Phased Array, 3.0-8.0MHz8P1 Phased Array, 4.0-12.0MHzMulti-port connector connects | 2P1 Phased Array, 2.0-4.0MHz5P1 Phased Array, 4.0-7.0MHzMulti-port connector connects | |||
| 4 transducers | 2 transducers | |||
| 8 | AcousticTrack | TRACK 3 | TRACK 3 | Same |
Table 5 Functions Comparison
| ID | ComparisonItems | Proposed DeviceSonoScape S40 | Predicate DeviceSonoScape S6 | Remark |
|---|---|---|---|---|
| 9 | Based on an embedded Linuxoperating system. | Based on an embedded Linuxoperating system. | Same | |
| Design | Based on a 128 channel fulldigital beam former. | Based on a 64 channel fulldigital beam former. | SEAnalysis2 | |
| Autocorrelation for colorprocessing and FFT for pulse | Autocorrelation for colorprocessing and FFT for pulse | Same | ||
| ID | ComparisonItems | Proposed DeviceSonoScape S40and CW Doppler processing. | Predicate DeviceSonoScape S6and CW Doppler processing. | Remark |
| Supporting Linear, Curve linearand Phase array probes from 2to 15 MHz. | Supporting Linear, Curve linearand Phase array probes from 2to 15 MHz. | Same | ||
| Cine play back capability | Cine play back capability | Same | ||
| Image file archive | Image file archive | Same | ||
| Software upgrade with USBflash drive. | Software upgrade with USBflash drive. | Same | ||
| Digital Scan Converter800×600 | Digital Scan Converter800×600 | Same | ||
| With touch panel | With full keyboard | SEAnalysis3 | ||
| TGC 8 slider | TGC 8 slider | Same | ||
| Depth Range: 3 to 32 cm | Depth Range: 3 to 32 cm | Same | ||
| Image sector size: 32 lines tofull B (512 lines) | Image sector size: 32 lines tofull B (256 lines) | SEAnalysis4 | ||
| Image Sector position: Steeringwithin full maximum | Image Sector position: Steeringwithin full maximum | Same | ||
| B orientation flip :L/R key withmarking on the screen | B orientation flip :L/R key withmarking on the screen | Same | ||
| B Dynamic range control:preset 14 curves over 140 dB | B Dynamic range control:preset 14 curves over 140 dB | Same | ||
| Gray Scale Control: 7 Settings | Gray Scale Control: 7 Settings | Same | ||
| Focal Number: 12 focal zonesetting | Focal Number: 12 focal zonesetting | Same | ||
| 10 | OperationControls | B persistence: 0-95% | B persistence: 0-95% | Same |
| Image Processing: Smoothing,edge enhancement | Image Processing: Smoothing,edge enhancement | Same | ||
| PW sweeping speed 2,4,6,8sec over display | PW sweeping speed 2,4,6,8sec over display | Same | ||
| PW Wall filter setting:16settings,25 to 750 HZ | PW Wall filter setting:16settings,25 to 750 HZ | Same | ||
| PW sample volume:0.5 to20mm | PW sample volume:0.5 to20mm | Same | ||
| PW/B update: with UPDATEkey | PW/B update: with UPDATEkey | Same | ||
| PW cursor steering: Steer softkey | PW cursor steering: Steer softkey | Same | ||
| PW angle correction:0 to 80degree user control | PW angle correction:0 to 80degree user control | Same | ||
| ID | Comparison Items | Proposed Device SonoScape S40 | Predicate Device SonoScape S6 | Remark |
| PW spectrum dynamic range:10 preset curve over 15-48 dB | PW spectrum dynamic range:10 preset curve over 15-48 dB | Same | ||
| Spectrum baseline shift and invert | Spectrum baseline shift and invert | Same | ||
| Color ROI setting: trackball and set key to control size and position | Color ROI setting: trackball and set key to control size and position | Same | ||
| Color steering on flat probe: $\pm$ 20, $\pm$ 16,0 | Color steering on flat probe: $\pm$ 20, $\pm$ 16,0 | Same | ||
| Color Wall Filter: Color wall filter with 16 selection, 25-750 of PRF | Color Wall Filter: Color wall filter with 16 selection, 25-750 of PRF | Same | ||
| Color priority-B priority soft menu | Color priority-B priority soft menu | Same | ||
| Color Packet size: preset per Exam, horizontal, vertical, off | Color Packet size: preset per Exam, horizontal, vertical, off | Same | ||
| Zoom adjustable | Zoom adjustable | Same | ||
| Freeze control: Toggling freeze key | Freeze control: Toggling freeze key | Same | ||
| Cine control: step, play backward, play continuously | Cine control: step, play backward, play continuously | Same | ||
| 11 | Operation Mode | B, M, PW, CW, CFM, DPI, TDI, Tissue Harmonic Image 3D/4D Mode Color M Mode | B, M, PW, CW, CFM, DPI, TDI, Tissue Harmonic Image 3D/4D Mode Color M Mode | Same |
| 12 | Display Modes | Dual B, Quad Display, B and M, B and Doppler B + Color, Dual B(Flow) Triplex mode: B,CFM, and PW/CW; B,DPI, and PW/CW;B,THI and Color M, steer M Dual B and Color in real time Compound Imaging, Panoramic Imaging, Trapezoid Imaging. | Dual B, Quad Display, B and M, B and Doppler B + Color, Dual B(Flow) Triplex mode: B,CFM, and PW/CW; B,DPI, and PW/CW;B,THI and Color M, steer M Dual B and Color in real time Compound Imaging, Panoramic Imaging, Trapezoid Imaging. | Same |
| 13 | Measurement Items | Distance; area; circumference; calipers; volume, velocity, HR, PI, RI. Cardiac. OB/GYN, Urology, Vascular and small | Distance; area; circumference; calipers; volume, velocity, HR, PI, RI. Cardiac. OB/GYN, Urology, Vascular and small | Same |
| ID | ComparisonItems | Proposed DeviceSonoScape S40 | Predicate DeviceSonoScape S6 | Remark |
| part package | part package | |||
| 14 | Cine Loop | Automatic review/ manualreview | Automatic review/ manualreview | Same |
| Review speed can be adjusted | Review speed can be adjusted | Same |
510(k) Summary
8-6
{6}------------------------------------------------
:
:
·
·
510(k) Submission
510(k) Summary
.
8-7
.
{7}------------------------------------------------
510(k) Submission .
510(k) Summary
:
.
8-8
.
{8}------------------------------------------------
510(k) Submission
Table 6 Specifications Comparison
.
| ID | ComparisonItems | Proposed DeviceSonoScape S40 | Predicate DeviceSonoScape S6 | Remark | ||||
|---|---|---|---|---|---|---|---|---|
| 15 | PowerSupply | Voltage: 110-127/220-240 VACFrequency: 50/60 HzPower Consumption: 450VA | Voltage: 110-240 VACFrequency: 50/60 HzPower Consumption: 110-240V AC, 2.7-1.2A | SEAnalysis5 | ||||
| 16 | OperatingCondition | Temperature: 10 | Temperature: 10 | Same | ||||
| 17 | StorageCondition | Temperature: -20 | Temperature: -20 | Same | ||||
| 18 | Screen Size | 18.5 inch Widescreen LCDmonitor | 15 inch Widescreen LCD monitor | SEAnalysis6 | ||||
| 19 | MeasurementAccuracy | Parameter | Value range | Errorrange | Parameter | Value range | Errorrange | |
| Displaydepth | Max 32.9 cm; (Probedepend) | ±3% | Displaydepth | Max 32.9 cm; (Probedepend) | ±3% | Same | ||
| Distance | 0~31.0 cm | ±3% | Distance | 0~31.0 cm | ±3% | Same | ||
| Area | Max. ≥855 cm² | ±7% | Area | Max. ≥855 cm² | ±7% | Same | ||
| Angle | 10~193° | ±3% | Angle | 10~193° | ±3% | Same | ||
| Circumference | 200 cm | ±3% | Circumference | 200 cm | ±3% | Same | ||
| Volume | Max. 25000 cm³ | ±10% | Volume | Max. 25000 cm³ | ±10% | Same | ||
| M-Modetime | 2,4,6,8 S | ±1% | M-Modetime | 2,4,6,8 S | ±1% | Same | ||
| HeartRate | 8 ~ 1000beats/sec | ±3% | HeartRate | 8 ~ 1000beats/sec | ±3% | Same | ||
| Slope | 1300 cm/s | ±3% | Slope | 1300 cm/s | ±3% | Same |
510(k) Summary
{9}------------------------------------------------
510(k) Submission
| ID | Comparison Items | Proposed Device SonoScape S40 | Predicate Device SonoScape S6 | Remark | ||
|---|---|---|---|---|---|---|
| Velocity | Angle | Velocity | Angle | |||
| Velocity (PW) | 0.04-2940 cm/s | ≤60°, ≤5% | 0.04-2940 cm/s | ≤60°, ≤5% | Same | |
| Velocity (CW) | 0.12-3795 cm/s | ≤60°, ≤5% | 0.13-3529 cm/s | ≤60°, ≤5% | SE Analysis 7 | |
| Velocity (Color) | 1-298 cm/s | ≤60°, ≤5% | 2-226cm/s | ≤60°, ≤5% | ||
| 20 | Acoustic Output | Track 3:MI, TIS, TIC, TIBDerated ispta: 720Mw/cm2 maximum.TIS/TIB/TIC: 6.0 Maximum,Mechanical Index: 1.9 Maximum,or Derated Isppa: 190W/cm2 max | ||||
| Same |
Table 7 Safety Comparison
| ID | Comparison Items | Proposed DeviceSonoScape S40 | Predicate DeviceSonoScape S6 | Remark |
|---|---|---|---|---|
| 21 | Electrical Safety | -IEC 60601-1 | -IEC 60601-1 | Same |
| 22 | EMC | -IEC 60601-1-2 | -IEC 60601-1-2 | Same |
| 23 | Performance | -IEC 60601-2-37 | -IEC 60601-2-37 | Same |
| 24 | Biocompatibility | -ISO 10993-5,-ISO 10993-10 | -ISO 10993-5,-ISO 10993-10 | Same |
| 25 | Level of ConcernOf Software | Moderate level ofconcern system | Moderate level ofconcern system | Same |
SE Analysis 1:
Probe Type & Connectors, Compare to the predicate device, the proposed device is with different probe type or frequency, such as L752, C353 etc. But no new intended use is added and all of them comply with IEC 60601-2-37; And the proposed device has 4 probe connection ports and the predicate device has 2 probe connection ports, but both of them comply with IEC 60601-1 and IEC 60601-1-2, therefore they can be considered Substantially Equivalent in safety and effectiveness, and no new risk is raised, so the SE is not affected.
{10}------------------------------------------------
SE Analysis 2: ·
The proposed device is based on a 128 channel full digital beam former and the predicate device is 64, but the 128 channel is better than 64 channel in terms of the image quality. Therefore, they can be considered Substantially Equivalent in safety and effectiveness. So the SE is not affected.
SE Analysis 3:
The predicate device is with full keyboard and the proposed device is not, but both of them comply with IEC 60601-1 and IEC 60601-1-2. Therefore, they can be considered Substantially Equivalent in safety and effectiveness. So the SE is not affected.
SE Analysis 4:
The proposed device is with 512 lines image sector size and the predicate device is 256, but the 512 lines is better than 256 lines in terms of the image quality. Therefore, they can be considered Substantially Equivalent in safety and effectiveness. So the SE is not affected.
SE Analysis 5
The Power Supply of the proposed device and the predicate device are 110-127/220-240 VAC, 450VA and 110-240VAC, 2.7-1.2A respectively, but both of them comply with IEC60601-1 and IEC 60601-1-2. Therefore, power supply can be considered Substantially Equivalent in safety and effectiveness.
SE Analysis 6
The screen size of the proposed is larger than that of the S6. This difference is considered to have no effect on effectiveness and safety.
SE Analysis 7:
The proposed device and the predicate device are with different measurement accuracy in Velocity (CW/ Color), but the proposed device is better. Therefore, they can be considered Substantially Equivalent in safety and effectiveness. So the SE is not affected.
Discussion of Substantially Equivalent
The subject device has same intended use, similar product design, and same performance effectiveness, performance safety as the predicate device. The differences above between the subject device and predicate device do not affect the basic design
8-11
{11}------------------------------------------------
K131213
Page 12 of 12
510(k) Submission
principle, usage, effectiveness and safety of the subject device. And no question is raised regarding to effectiveness and safety.
10. Substantially Equivalent Conclusion
In accordance with the Federal Food, Drug and Cosmetic Act, 21 CFR Part 807 and based on the information provided in this premarket notification, SonoScape Company Limited concludes that S40 Digital Color Doppler Ultrasound System is substantially equivalent to predicate devices with regard to safety and effectiveness.
510(k) Summary
{12}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/12/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" around the perimeter. Inside the circle is an abstract symbol that resembles an eagle or bird-like figure with three wing-like shapes.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
June 21, 2013
SonoScape Company Limited % Ms. Toki Wu Yizhe Building, Yuquan Road, NanShan Shenzhen, Guangdong 518051 P.R. CHINA
Re: K131213
Trade/Device Name: S40 Digital Color Doppler Ultrasound System Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed echo imaging system Regulatory Class: Class II Product Code: IYN, IYO, and ITX Dated: April 26, 2013 Received: May 2, 2013
Dear Ms. Wu:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
This determination of substantial equivalence applies to the following transducers intended for use with the S40 Digital Color Doppler Ultrasound System, as described in your premarket notification:
Transducer Model Number
2P2 Phase Array 8P1 Phase Array C344 Curved Array VC6-2 Curved Array 3PI Phase Array 6V1 Micro-curved Array C353 Curved Array L741 Linear Array L752 Linear Array
5P2 Phase Array 6V3 Micro-curved Array C322 Curved Array L742 Linear Array
{13}------------------------------------------------
Page 2 - Ms. Toki Wu
If your device is classified (see above) into cither class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA 's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050;
This letter will allow you to begin marketing your device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/About/DA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH) s) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
If you have any questions regarding the content of this letter, please contact Shing Chun Benny Lam, Ph.D. at (301) 796-9328.
Sincerely yours,

for
Janine M. Morris Director, Division of Radiological Devices Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosures
{14}------------------------------------------------
Indications for Use
| 510(k) Number: | K131213 |
|---|---|
| Device Name: | S40 Digital Color Doppler Ultrasound System |
| Indications for Use: | The SonoScape S40 device is a general-purpose ultrasonicimaging instrument intended for use by a qualifiedphysician for evaluation of Fetal, Abdominal, Pediatric,Small Organ (breast, testes, thyroid), Cephalic(neonataland adult), Trans-rectal, Trans-vaginal, PeripheralVascular, Musculo-skeletal (Conventional and Superficial),Cardiac (neonatal and adult), OB/Gyn and Urology. |
Prescription Use _____________________________________________________________________________________________________________________________________________________________ (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use _ (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
$m(x-h)
(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health
K131213 510(k) _
Indications for Use
Page 1 of 15
{15}------------------------------------------------
System: SonoScape S40
Diagnostic Ultrasound Pulsed Echo System
Diagnostic Ultrasound Pulsed Doppler Imaging System
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| General(TRACK 1ONLY) | Specific(TRACKS 1 & 3) | B | M | PWD | CWD | ColorDoppler | Power(Amplitude)Doppler | Other*Combined | Other*Specify | |
| Ophthalmic | Ophthalmic | |||||||||
| Fetal | N | N | N | N | N | Note 1 | Notes 2,4,5 | |||
| Abdominal | N | N | N | N | N | Note 1 | Notes 2,4,5 | |||
| Intra-operative Specify | ||||||||||
| Intra-operative Neuro | ||||||||||
| Laparoscopic | ||||||||||
| Pediatric | N | N | N | N | N | Note 1 | Notes 2,4 | |||
| Small Organ (specify) | N | N | N | N | N | Note 1 | Notes 2,4,6 | |||
| Neonatal Cephalic | N | N | N | N | N | N | Note 1 | Notes 2,3,4 | ||
| Fetal | Adult Cephalic | N | N | N | N | N | N | Note 1 | Notes 2,3,4 | |
| Imaging& | Trans-rectal | N | N | N | N | N | Note 1 | Notes 2,4 | ||
| Other | Trans-vaginal | N | N | N | N | N | Note 1 | Notes 2,4 | ||
| Trans-urethral | ||||||||||
| Trans-esoph.(non-Card) | ||||||||||
| Musculo-skeletal(Conventional) | N | N | N | N | N | Note 1 | Notes 2,4 | |||
| Musculo-skeletal(Superficial) | N | N | N | N | N | Note 1 | Notes 2,4 | |||
| Intravascular | ||||||||||
| Other (Ob/GYN) | N | N | N | N | N | Note 1 | Notes 2,4,5 | |||
| Cardiac Adult | N | N | N | N | N | N | Note 1 | Notes 2,3,4 | ||
| Cardiac Pediatric | N | N | N | N | N | N | Note 1 | Notes 2,3,4 | ||
| Cardiac | Intravascular(Cardiac) | |||||||||
| Trans-esoph.(Cardiac) | ||||||||||
| Intra-cardiac | ||||||||||
| Other (specify) | ||||||||||
| Peripheral | Peripheral vessel | N | N | N | N | N | Note 1 | Notes 2,4 | ||
| Vessel | Other (specify) |
E = added under this appendix P = previously cleared by FDA; N = new indication; Note 1: Other Combined includes: BM; B/PWD; B/THI; M/Color Doppler; B/Color Doppler/PWD; B/Power Doppler/PWD
Note 2: Tissue Harmonic Imaging. The feature does not use contrast agents
Note 3: TDI Note 4: 3D Note 5: 4D
Note 6: Small Organ: breast, thyroid, testes
(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health
510(k) _
Indications for Use
Page 2 of 15
{16}------------------------------------------------
Transducer: 2P2 Phase Array
Diagnostic Ultrasound Transducer
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| General(TRACK 1ONLY) | Specific(TRACKS 1 & 3) | B | M | PWD | CWD | ColorDoppler | Power(Amplitude)Doppler | Other*Combined | Other*Specify |
| Ophthalmic | Ophthalmic | ||||||||
| FetalImaging&Other | Fetal | ||||||||
| Abdominal | N | N | N | N | N | Note 1 | Notes 2,4 | ||
| Intra-operative Specify | |||||||||
| Intra-operative Neuro | |||||||||
| Laparoscopic | |||||||||
| Pediatric | |||||||||
| Small Organ (specify) | |||||||||
| Neonatal Cephalic | N | N | N | N | N | N | Note 1 | Notes 2,3,4 | |
| Adult Cephalic | N | N | N | N | N | N | Note 1 | Notes 2,3,4 | |
| Trans-rectal | |||||||||
| Trans-vaginal | |||||||||
| Trans-urethral | |||||||||
| Trans-esoph.(non-Card) | |||||||||
| Musculo-skeletal(Conventional) | |||||||||
| Musculo-skeletal(Superficial) | |||||||||
| Intravascular | |||||||||
| Other (Ob/GYN) | |||||||||
| Cardiac | Cardiac Adult | N | N | N | N | N | N | Note 1 | Notes 2,3,4 |
| Cardiac Pediatric | N | N | N | N | N | N | Note 1 | Notes 2,3,4 | |
| Intravascular(Cardiac) | |||||||||
| Trans-esoph. (Cardiac) | |||||||||
| Intra-cardiac | |||||||||
| Other (specify) | |||||||||
| PeripheralVessel | Peripheral vessel | ||||||||
| Other (specify) |
P = previously cleared by FDA; E = added under this appendix N = new indication; Note 1: Other Combined includes: B/M; B/PWD; B/THI; M/Color M; B/Color Doppler; B/Color Doppler/PWD; B/Power Doppler/PWD
Note 2: Tissue Harmonic Imaging. The feature does not use contrast agents
Note 3: TDI Note 4: 3D Note 5: 4D
Note 6: Small Organ: breast, thyroid, testes
(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health
510(k) _
Indications for Use
Page 3 of 15
{17}------------------------------------------------
Transducer: 3P1 Phase Array
Diagnostic Ultrasound Transducer
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| General(TRACK 1ONLY) | Specific(TRACKS 1 & 3) | B | M | PWD | CWD | ColorDoppler | Power(Amplitude) Doppler | Other*Combined | Other*Specify | |
| Ophthalmic | Ophthalmic | |||||||||
| FetalImaging&Other | Fetal | |||||||||
| Abdominal | N | N | N | N | N | Note 1 | Notes 2,4 | |||
| Intra-operative Specify | ||||||||||
| Intra-operative Neuro | ||||||||||
| Laparoscopic | ||||||||||
| Pediatric | ||||||||||
| Small Organ (specify) | ||||||||||
| Neonatal Cephalic | N | N | N | N | N | N | Note 1 | Notes 2,3,4 | ||
| Adult Cephalic | N | N | N | N | N | N | Note 1 | Notes 2,3,4 | ||
| Trans-rectal | ||||||||||
| Trans-vaginal | ||||||||||
| Trans-urethral | ||||||||||
| Trans-esoph(non-Card) | ||||||||||
| Musculo-skeletal(Conventional) | ||||||||||
| Musculo-skeletal(Superficial) | ||||||||||
| Intravascular | ||||||||||
| Other (Ob/GYN) | ||||||||||
| Cardiac | Cardiac Adult | N | N | N | N | N | N | Note 1 | Notes 2,3,4 | |
| Cardiac Pediatric | N | N | N | N | N | N | Note 1 | Notes 2,3,4 | ||
| Intravascular(Cardiac) | ||||||||||
| Trans-esoph. (Cardiac) | ||||||||||
| Intra-cardiac | ||||||||||
| Other (specify) | ||||||||||
| PeripheralVessel | Peripheral vessel | |||||||||
| Other (specify) |
N = new indication; P = previously cleared by FDA; E = added under this appendix Note 1: Other Combined includes: B/M; B/PWD; B/THI; M/Color M; B/Color Doppler; B/Color Doppler/PWD; B/Power Doppler/PWD
Note 2: Tissue Harmonic Imaging. The feature does not use contrast agents
Note 3: TDI Note 4: 3D Note 5: 4D
Note 6: Small Organ: breast, thyroid, testes
(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health
510(k) __
Indications for Use
Page 4 of 15
{18}------------------------------------------------
Transducer: 5P2 Phase Array
Diagnostic Ultrasound Transducer
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| General(TRACK 1ONLY) | Specific(TRACKS 1 & 3) | B | M | PWD | CWD | ColorDoppler | Power(Amplitude) Doppler | Other*Combined | Other*Specify |
| Ophthalmic | Ophthalmic | ||||||||
| FetalImaging&Other | Fetal | ||||||||
| Abdominal | |||||||||
| Intra-operative Specify | |||||||||
| Intra-operative Neuro | |||||||||
| Laparoscopic | |||||||||
| Pediatric | N | N | N | N | N | Note 1 | Notes 2,4 | ||
| Small Organ (specify) | |||||||||
| Neonatal Cephalic | N | N | N | N | N | N | Note 1 | Notes 2,3,4 | |
| Adult Cephalic | |||||||||
| Trans-rectal | |||||||||
| Trans-vaginal | |||||||||
| Trans-urethral | |||||||||
| Trans-esoph(non-Card) | |||||||||
| Musculo-skeletal(Conventional) | |||||||||
| Musculo-skeletal(Superficial) | |||||||||
| Intravascular | |||||||||
| Other (Ob/GYN) | |||||||||
| Cardiac | Cardiac Adult | ||||||||
| Cardiac Pediatric | N | N | N | N | N | N | Note 1 | Notes 2,3,4 | |
| Intravascular(Cardiac) | |||||||||
| Trans-esoph. (Cardiac) | |||||||||
| Intra-cardiac | |||||||||
| Other (specify) | |||||||||
| PeripheralVessel | Peripheral vessel | ||||||||
| Other (specify) |
P = previously cleared by FDA; E = added under this appendix N = new indication; Note 1: Other Combined includes: B/M; B/PWD; B/THI; M/Color M; B/Color Doppler; B/Color
Doppler/PWD; B/Power Doppler/PWD
Note 2: Tissue Harmonic Imaging. The feature does not use contrast agents
Note 3: TD! Note 4: 3D Note 5: 4D
Note 6: Small Organ: breast, thyroid, testes
(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health
510(k) __
Indications for Use
Page 5 of 15
{19}------------------------------------------------
Transducer: 8P1 Phase Array
Diagnostic Ultrasound Transducer
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| General(TRACK 1ONLY) | Specific(TRACKS 1 & 3) | B | M | PWD | CWD | ColorDoppler | Power(Amplitude) Doppler | Other*Combined | Other*Specify |
| Ophthalmic | Ophthalmic | ||||||||
| FetalImaging&Other | Fetal | ||||||||
| Abdominal | |||||||||
| Intra-operative Specify | |||||||||
| Intra-operative Neuro | |||||||||
| Laparoscopic | |||||||||
| Pediatric | N | N | N | N | N | Note 1 | Notes 2,4 | ||
| Small Organ (specify) | |||||||||
| Neonatal Cephalic | N | N | N | N | N | N | Note 1 | Notes 2,3,4 | |
| Adult Cephalic | |||||||||
| Trans-rectal | |||||||||
| Trans-vaginal | |||||||||
| Trans-urethral | |||||||||
| Trans-esoph(non-Card) | |||||||||
| Musculo-skeletal(Conventional) | |||||||||
| Musculo-skeletal(Superficial) | |||||||||
| Intravascular | |||||||||
| Other (Ob/GYN) | |||||||||
| Cardiac | Cardiac Adult | ||||||||
| Cardiac Pediatric | N | N | N | N | N | N | Note 1 | Notes 2,3,4 | |
| Intravascular(Cardiac) | |||||||||
| Trans-esoph.(Cardiac) | |||||||||
| Intra-cardiac | |||||||||
| Other (specify) | |||||||||
| PeripheralVessel | Peripheral vessel | ||||||||
| Other (specify) |
N = new indication; P = previously cleared by FDA; E = added under this appendix Note 1: Other Combined includes: B/M; B/PWD; B/THI; M/Color M; B/Color Doppier; B/Color
Doppler/PWD; B/Power Doppler/PWD
Note 2: Tissue Harmonic Imaging. The feature does not use contrast agents
Note 3: TDI Note 4: 3D Note 5: 4D
Note 6: Small Organ: breast, thyroid, testes
(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health
510(k) __
Indications for Use
Page 6 of 15
{20}------------------------------------------------
Transducer: 6V1 Micro-curved Array
Diagnostic Ultrasound Transducer
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | Other* | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| General(TRACK 1ONLY) | Specific(TRACKS 1 & 3) | B | M | PWD | CWD | ColorDoppler | Power(Amplitude)Doppler | Other*Combined | Other*Specify | |
| Ophthalmic | Ophthalmic | |||||||||
| FetalImaging&Other | Fetal | |||||||||
| Abdominal | ||||||||||
| Intra-operative Specify | ||||||||||
| Intra-operative Neuro | ||||||||||
| Laparoscopic | ||||||||||
| Pediatric | ||||||||||
| Small Organ (specify) | ||||||||||
| Neonatal Cephalic | ||||||||||
| Adult Cephalic | ||||||||||
| Trans-rectal | P | P | P | P | P | Note 1 | Notes 2,4 | |||
| Trans-vaginal | P | P | P | P | P | Note 1 | Notes 2,4 | |||
| Trans-urethral | ||||||||||
| Trans-esoph.(non-Card) | ||||||||||
| Musculo-skeletal(Conventional) | ||||||||||
| Musculo-skeletal(Superficial) | ||||||||||
| Intravascular | ||||||||||
| Other (Ob/GYN) | ||||||||||
| Cardiac | Cardiac Adult | |||||||||
| Cardiac Pediatric | ||||||||||
| Intravascular(Cardiac) | ||||||||||
| Trans-esoph.(Cardiac) | ||||||||||
| Intra-cardiac | ||||||||||
| Other (specify) | ||||||||||
| PeripheralVessel | Peripheral vessel | |||||||||
| Other (specify) |
N = new indication; P = previously cleared by FDA; E = added under this appendix Note 1: Other Combined includes: B/M; B/PWD; B/THI; M/Color M; B/Color Doppler; B/Color
Doppler/PWD; B/Power Doppler/PWD
Note 2: Tissue Harmonic Imaging. The feature does not use contrast agents
Note 3: TDI Note 5: 4D Note 4: 3D
Note 6: Small Organ: breast, thyroid, testes
(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health
510(k) _
Indications for Use
Page 7 of 15
{21}------------------------------------------------
Transducer: 6V3 Micro-curved Array
Diagnostic Ultrasound Transducer
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | Other* | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| General(TRACK 1ONLY) | Specific(TRACKS 1 & 3) | B | M | PWD | CWD | ColorDoppler | Power(Amplitude)Doppler | Combined | Specify | ||
| Ophthalmic | Ophthalmic | ||||||||||
| FetalImaging&Other | Fetal | ||||||||||
| Abdominal | |||||||||||
| Intra-operative Specify | |||||||||||
| Intra-operative Neuro | |||||||||||
| Laparoscopic | |||||||||||
| Pediatric | |||||||||||
| Small Organ (specify) | |||||||||||
| Neonatal Cephalic | |||||||||||
| Adult Cephalic | |||||||||||
| Trans-rectal | P | P | P | P | P | Note 1 | Notes 2,4 | ||||
| Trans-vaginal | P | P | P | P | P | Note 1 | Notes 2,4 | ||||
| Trans-urethral | |||||||||||
| Trans-esoph. (non-Card) | |||||||||||
| Musculo-skeletal(Conventional) | |||||||||||
| Musculo-skeletal(Superficial) | |||||||||||
| Intravascular | |||||||||||
| Other (Ob/GYN) | |||||||||||
| Cardiac | Cardiac Adult | ||||||||||
| Cardiac Pediatric | |||||||||||
| Intravascular(Cardiac) | |||||||||||
| Trans-esoph. (Cardiac) | |||||||||||
| Intra-cardiac | |||||||||||
| Other (specify) | |||||||||||
| PeripheralVessel | Peripheral vessel | ||||||||||
| Other (specify) |
N = new indication; P = previously cleared by FDA; E = added under this appendix Note 1: Other Combined includes: B/M; B/PWD; B/THI; M/Color M; B/Color Doppler; B/Color
Doppler/PWD; B/Power Doppler/PWD
Note 2: Tissue Harmonic Imaging. The feature does not use contrast agents
Note 3: TDI Note 4: 3D Note 5: 4D
Note 6: Small Organ: breast, thyroid, testes
(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health
510(k) _
Indications for Use
Page 8 of 15
{22}------------------------------------------------
Transducer: C344 Curved Array
Diagnostic Ultrasound Transducer
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| General(TRACK 1ONLY) | Specific(TRACKS 1 & 3) | B | M | PWD | CWD | ColorDoppler | Power(Amplitude)Doppler | Other*Combined | Other*Specify |
| Ophthalmic | Ophthalmic | ||||||||
| FetalImaging&Other | Fetal | P | P | P | P | P | Note 1 | Notes 2,4 | |
| Abdominal | P | P | P | P | P | Note 1 | Notes 2,4 | ||
| Intra-operative Specify | |||||||||
| Intra-operative Neuro | |||||||||
| Laparoscopic | |||||||||
| Pediatric | |||||||||
| Small Organ (specify) | |||||||||
| Neonatal Cephalic | |||||||||
| Adult Cephalic | |||||||||
| Trans-rectal | |||||||||
| Trans-vaginal | |||||||||
| Trans-urethral | |||||||||
| Trans-esoph.(non-Card) | |||||||||
| Musculo-skeletal(Conventional) | |||||||||
| Musculo-skeletal(Superficial) | |||||||||
| Intravascular | |||||||||
| Other (Ob/GYN) | P | P | P | P | P | Note 1 | Notes 2.4 | ||
| Cardiac | Cardiac Adult | ||||||||
| Cardiac Pediatric | |||||||||
| Intravascular(Cardiac) | |||||||||
| Trans-esoph.(Cardiac) | |||||||||
| Intra-cardiac | |||||||||
| Other (specify) | |||||||||
| PeripheralVessel | Peripheral vessel | ||||||||
| Other (specify) |
P = previously cleared by FDA; E = added under this appendix N = new indication; Note 1: Other Combined includes: B/M; B/PWD; B/THI; M/Color M; B/Color Doppler; B/Color Doppler/PWD; B/Power Doppter/PWD
Note 2: Tissue Harmonic Imaging. The feature does not use contrast agents
Note 3: TDI Note 4: 3D Note 5: 4D
Note 6: Small Organ: breast, thyroid, testes
(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health
510(k) _
Indications for Use
Page 9 of 15
{23}------------------------------------------------
Transducer: C353 Curved Array
Diagnostic Ultrasound Transducer
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | Other* | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| General(TRACK 1ONLY) | Specific(TRACKS 1 & 3) | B | M | PWD | CWD | ColorDoppler | Power(Amplitude)Doppler | Combined | Specify | |
| Ophthalmic | Ophthalmic | |||||||||
| FetalImaging&Other | Fetal | N | N | N | N | N | Note 1 | Notes 2,4 | ||
| Abdominal | N | N | N | N | N | Note 1 | Notes 2,4 | |||
| Intra-operative Specify | ||||||||||
| Intra-operative Neuro | ||||||||||
| Laparoscopic | ||||||||||
| Pediatric | ||||||||||
| Small Organ (specify) | ||||||||||
| Neonatal Cephalic | ||||||||||
| Adult Cephalic | ||||||||||
| Trans-rectal | ||||||||||
| Trans-vaginal | ||||||||||
| Trans-urethral | ||||||||||
| Trans-esoph.(non-Card) | ||||||||||
| Musculo-skeletal(Conventional) | ||||||||||
| Musculo-skeletal(Superficial) | ||||||||||
| Intravascular | ||||||||||
| Other (Ob/GYN) | N | N | N | N | N | Note 1 | Notes 2,4 | |||
| Cardiac | Cardiac Adult | |||||||||
| Cardiac Pediatric | ||||||||||
| Intravascular(Cardiac) | ||||||||||
| Trans-esoph. (Cardiac) | ||||||||||
| Intra-cardiac | ||||||||||
| Other (specify) | ||||||||||
| PeripheralVessel | Peripheral vessel | |||||||||
| Other (specify) |
N = new indication; Note 1: Other Combined includes: B/M; B/PWD; B/THI; M/Color M; B/Color Doppler; B/Color Doppler/PWD: B/Power Doppler/PWD
Note 2: Tissue Harmonic Imaging. The feature does not use contrast agents
Note 3: TDI Note 4: 3D Note 5: 4D .
Note 6: Small Organ: breast, thyroid, testes
(Division Sign Off) Division of Radiological Health Office of in Vitro Diagnostic and Radiological Health
510(k) _
Indications for Use
Page 10 of 15
{24}------------------------------------------------
Transducer: C322 Curved Array
Diagnostic Ultrasound Transducer
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | Other* | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| General(TRACK 1ONLY) | Specific(TRACKS 1 & 3) | B | M | PWD | CWD | ColorDoppler | Power(Amplitude)Doppler | Combined | Specify | |
| Ophthalmic | Ophthalmic | |||||||||
| FetalImaging&Other | Fetal | N | N | N | N | N | Note 1 | Notes 2,4 | ||
| Abdominal | N | N | N | N | N | Note 1 | Notes 2,4 | |||
| Intra-operative Specify | ||||||||||
| Intra-operative Neuro | ||||||||||
| Laparoscopic | ||||||||||
| Pediatric | ||||||||||
| Small Organ (specify) | ||||||||||
| Neonatal Cephalic | ||||||||||
| Adult Cephalic | ||||||||||
| Trans-rectal | ||||||||||
| Trans-vaginal | ||||||||||
| Trans-urethral | ||||||||||
| Trans-esoph.(non-Card) | ||||||||||
| Musculo-skeletal(Conventional) | ||||||||||
| Musculo-skeletal(Superficial) | ||||||||||
| Intravascular | ||||||||||
| Other (Ob/GYN) | N | N | N | N | N | Note 1 | Notes 2,4 | |||
| Cardiac | Cardiac Adult | |||||||||
| Cardiac Pediatric | ||||||||||
| Intravascular(Cardiac) | ||||||||||
| Trans-esoph.(Cardiac) | ||||||||||
| Intra-cardiac | ||||||||||
| Other (specify) | ||||||||||
| PeripheralVessel | Peripheral vessel | |||||||||
| Other (specify) |
N = new indication; P = previously cleared by FDA; E = added under this appendix Note 1: Other Combined includes: B/M; B/PWD; B/THI; M/Color M; B/Color Doppler; B/Color Doppler/PWD; B/Power Doppler/PWD
Note 2: Tissue Harmonic Imaging. The feature does not use contrast agents
Note 3: TDI Note 4: 3D Note 5: 4D
Note 6: Small Organ: breast, thyroid, testes
(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health
510(k) _
Page 11 of 15
{25}------------------------------------------------
Transducer: VC6-2 Curved Array
Diagnostic Ultrasound Transducer
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| General | Specific | Color | · Power | Other | Other | ||||
| (TRACK 1ONLY) | (TRACKS 1 & 3) | B | M | PWD | CWD | Doppler | (Amplitude)Doppler | Combined | Specify |
| Ophthalmic | Ophthalmic | ||||||||
| Fetal | Fetal | P | P | P | P | P | Note 1 | Notes 2,4,5 | |
| lmaging & | Abdominal | P | P | P | P | P | Note 1 | Notes 2,4,5 | |
| Other | Intra-operative Specify | ||||||||
| Intra-operative Neuro | |||||||||
| Laparoscopic | |||||||||
| Pediatric | |||||||||
| Small Organ (specify) | |||||||||
| Neonatal Cephalic | |||||||||
| Adult Cephalic | |||||||||
| Trans-rectal | |||||||||
| Trans-vaginal | |||||||||
| Trans-urethral | |||||||||
| Trans-esoph (non-Card) | |||||||||
| Musculo-skeletal | |||||||||
| (Conventional) | |||||||||
| Musculo-skeletal | |||||||||
| (Superficial) | |||||||||
| Intravascular | |||||||||
| Other (Ob/GYN) | P | P | P | P | P | Note 1 | Notes 2,4,5 | ||
| Cardiac | Cardiac Adult | ||||||||
| Cardiac Pediatric | |||||||||
| Intravascular(Cardiac) | |||||||||
| Trans-esoph. (Cardiac) | |||||||||
| Intra-cardiac | |||||||||
| Other (specify) | |||||||||
| Peripheral | Peripheral vessel | ||||||||
| Vessel | Other (specify) |
N = new indication; P = previously cleared by FDA; E = added under this appendix Note 1: Other Combined includes: B/M; B/PWD; B/THI; M/Color Doppler; B/Color
Doppler/PWD; B/Power Doppler/PWD
Note 2: Tissue Harmonic Imaging. The feature does not use contrast agents
Note 4: 3D Note 5: 4D Note 3: TDI
Note 6: Small Organ: breast, thyroid, testes
(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health
510(k) __
Indications for Use
Page 12 of 15
{26}------------------------------------------------
Transducer: L741 Linear Array
Diagnostic Ultrasound Transducer
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| General(TRACK 1ONLY) | Specific(TRACKS 1 & 3) | B | M | PWD | CWD | ColorDoppler | Power(Amplitude)Doppler | Other*Combined | Other*Specify | |
| Ophthalmic | Ophthalmic | |||||||||
| FetalImaging&Other | Fetal | |||||||||
| Abdominal | ||||||||||
| Intra-operative Specify | ||||||||||
| Intra-operative Neuro | ||||||||||
| Laparoscopic | ||||||||||
| Pediatric | ||||||||||
| Small Organ (specify) | P | P | P | P | P | Note 1 | Notes 2,4,6 | |||
| Neonatal Cephalic | ||||||||||
| Adult Cephalic | ||||||||||
| Trans-rectal | ||||||||||
| Trans-vaginal | ||||||||||
| Trans-urethral | ||||||||||
| Trans-esoph.(non-Card) | ||||||||||
| Musculo-skeletal(Conventional) | P | P | P | P | P | P | Note 1 | Notes 2,4 | ||
| Musculo-skeletal(Superficial) | ||||||||||
| Intravascular | ||||||||||
| Other (Ob/GYN) | ||||||||||
| Cardiac | Cardiac Adult | |||||||||
| Cardiac Pediatric | ||||||||||
| Intravascular(Cardiac) | ||||||||||
| Trans-esoph. (Cardiac) | ||||||||||
| Intra-cardiac | ||||||||||
| Other (specify) | ||||||||||
| PeripheralVessel | Peripheral vessel | P | P | P | P | P | P | Note 1 | Notes 2,4 | |
| Other (specify) |
N = new indication; P = previously cleared by FDA; E = added under this appendix Note 1: Other Combined includes: B/M; B/PWD; B/THI; M/Color M; B/Color Doppler; B/Color
Doppler/PWD; B/Power Doppler/PWD
Note 2: Tissue Harmonic Imaging. The feature does not use contrast agents
Note 4: 3D Note 5: 4D Note 3: TDI
Note 6: Small Organ: breast, thyroid, testes
(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health
510(k) _
Indications for Use
Page 13 of 15
{27}------------------------------------------------
Transducer: L742 Linear Array
Diagnostic Ultrasound Transducer
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows;
| Clinical Application | Mode of Operation | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| General(TRACK 1ONLY) | Specific(TRACKS 1 & 3) | B | M | PWD | CWD | ColorDoppler | Power(Amplitude)Doppler | Other*Combined | Other*Specify |
| Ophthalmic | Ophthalmic | ||||||||
| Fetal | Fetal | ||||||||
| Imaging&Other | Abdominal | ||||||||
| Intra-operative Specify | |||||||||
| Intra-operative Neuro | |||||||||
| Laparoscopic | |||||||||
| Pediatric | |||||||||
| Small Organ (specify) | P | P | P | P | P | Note 1 | Notes 2,4,6 | ||
| Neonatal Cephalic | |||||||||
| Adult Cephalic | |||||||||
| Trans-rectal | |||||||||
| Trans-vaginal | |||||||||
| Trans-urethral | |||||||||
| Trans-esoph. (non-Card) | |||||||||
| Musculo-skeletal(Conventional) | P | P | P | P | P | Note 1 | Notes 2,4 | ||
| Musculo-skeletal(Superficial) | P | P | P | P | P | Note 1 | Notes 2,4 | ||
| Intravascular | |||||||||
| Other (Ob/GYN) | |||||||||
| Cardiac | Cardiac Adult | ||||||||
| Cardiac Pediatric | |||||||||
| Intravascular(Cardiac) | |||||||||
| Trans-esoph.(Cardiac) | |||||||||
| Intra-cardiac | |||||||||
| Other (specify) | |||||||||
| PeripheralVessel | Peripheral vessel | P | P | P | P | P | Note 1 | Notes 2,4 | |
| Other (specify) |
N = new indication; P = previously cleared by FDA; E = added under this appendix Note 1: Other Combined includes: B/M; B/PWD; B/THI; M/Color M; B/Color Doppler; B/Color Doppler/PWD; B/Power Doppler/PWD
Note 2: Tissue Harmonic Imaging. The feature does not use contrast agents
Note 4: 3D Note 5: 4D Note 3: TDI
Note 6: Small Organ: breast, thyroid, testes
(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health
510(k) .
Indications for Use
Page 14 of 15
{28}------------------------------------------------
Transducer: L752 Linear Array
Diagnostic Ultrasound Transducer
| Clinical Application | Mode of Operation | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| General(TRACK 1ONLY) | Specific(TRACKS 1 & 3) | B | M | PWD | CWD | ColorDoppler | Power(Amplitude)Doppler | Other*Combined | Other*Specify | |
| Ophthalmic | Ophthalmic | |||||||||
| FetalImaging&Other | Fetal | |||||||||
| Abdominal | ||||||||||
| Intra-operative Specify | ||||||||||
| Intra-operative Neuro | ||||||||||
| Laparoscopic | ||||||||||
| Pediatric | ||||||||||
| Small Organ (specify) | N | N | N | N | N | Note 1 | Notes 2,4,6 | |||
| Neonatal Cephalic | ||||||||||
| Adult Cephalic | ||||||||||
| Trans-rectal | ||||||||||
| Trans-vaginal | ||||||||||
| Trans-urethral | ||||||||||
| Trans-esoph.(non-Card) | ||||||||||
| Musculo-skeletal(Conventional) | N | N | N | N | N | Note 1 | Notes 2,4 | |||
| Musculo-skeletal(Superficial) | N | N | N | N | N | Note 1 | Notes 2,4 | |||
| Intravascular | ||||||||||
| Other (Ob/GYN) | ||||||||||
| Cardiac | Cardiac Adult | |||||||||
| Cardiac Pediatric | ||||||||||
| Intravascular(Cardiac) | ||||||||||
| Trans-esoph.(Cardiac) | ||||||||||
| Intra-cardiac | ||||||||||
| Other (specify) | ||||||||||
| PeripheralVessel | Peripheral vessel | N | N | N | N | N | Note 1 | Notes 2,4 | ||
| Other (specify) |
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
P = previously cleared by FDA; E = added under this appendix N = new indication; Note 1: Other Combined includes: B/M; B/PWD; B/THI; M/Color M; B/Color Doppler; B/Color
Doppler/PWD; B/Power Doppler/PWD
Note 2: Tissue Harmonic Imaging. The feature does not use contrast agents
Note 5: 4D Note 3: TDI Note 4: 3D
- Note 6: Small Organ: breast, thyroid, testes
(Division Sign Off) . Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health
510(k) ___
Indications for Use
Page 15 of 15
§ 892.1550 Ultrasonic pulsed doppler imaging system.
(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.